Basic Information
Basic information for LINC00662-216-13aa-2
Peptide Name LINC00662-216-13aa-2
Genome Position chr19:27727840-27727878[-]
Species Human
Peptide Sequence MYEEIFLRPVVKN
Peptide Length 13
Unique No (LINC00662-207-13aa,LINC00662-217-13aa,LINC00662-227-13aa,LINC00662-231-13aa-2,LINC00662-232-13aa,LINC00662-239-13aa,LINC00662-245-13aa-1,LINC00662-253-13aa,LINC00662-256-13aa,LINC00662-257-13aa-1,LINC00662-268-13aa-1,LINC00662-269-13aa,LINC00662-270-13aa-1,LINC00662-272-13aa,LINC00662-275-13aa)
Grand Average of Hydropathicity -0.0308
Relative Molecular Mass 1854.13
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000261824;LINC00662
Transcript ID/Name ENST00000654443;LINC00662-216
Transcript Length 2614
Coding Ability 0.2823
DNA Sequence Corresponding to Peptide ATGTATGAAGAGATATTTCTGAGGCCTGTTGTGAAAAAC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :